Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-09-01A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMTbioRxiv · 2026-08-27The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01First molecular record of Panaeolus subbalteatus (Psathyrellaceae, Agaricales) from Pakistan.Antonie van Leeuwenhoek · 2026-07-09Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Psychopharmacology · 2026-07-01Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-07-01Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits.bioRxiv: the preprint server for biology · 2026-06-15Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-01Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-04-01Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase).Psychiatry research · 2026-03-01Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-18A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy VolunteersClinicalTrials.gov · 2026-02-13COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDERGenetics and Molecular Research · 2026-01-01Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials.Journal of psychopharmacology (Oxford, England) · 2026-01-01Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use.Journal of psychoactive drugs · 2026-01-01Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.General hospital psychiatry · 2026-01-01Magic mushrooms and mood: Exploring psilocybin as a depression treatment.JPMA. The Journal of the Pakistan Medical Association · 2026-01-01The Effect of on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress.Journal of psychoactive drugs · 2026-01-01Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey.Journal of psychoactive drugs · 2026-01-01Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study.BJPsych open · 2025-12-15Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challengesMycological Progress · 2025-12-08Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain.Nature neuroscience · 2025-11-01Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg's Archives of Pharmacology · 2025-10-01An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.Progress in neuro-psychopharmacology & biological psychiatry · 2025-08-30Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.Journal of psychoactive drugs · 2025-07-0613. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-11The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-02-01Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health NurseSaudi Journal of Medicine and Public Health · 2024-12-31Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted PsychotherapyAnnals of Punjab Medical College · 2024-12-31Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsClinicalTrials.gov · 2024-10-24Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyClinicalTrials.gov · 2024-06-17Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic ReviewJournal For International Medical Graduates · 2024-04-18Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways.Ageing research reviews · 2024-04-01Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial.Canadian journal of pain = Revue canadienne de la douleur · 2024-01-01Psilocybin history, action and reaction: A narrative clinical review.Journal of psychopharmacology (Oxford, England) · 2023-09-01Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25Neurobiological Correlates of Psilocybin Response in Depression.The primary care companion for CNS disorders · 2023-05-23Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-10Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-05The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01Investigation of the Structure-Activity Relationships of Psilocybin Analogues.ACS pharmacology & translational science · 2021-04-09Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018Research Square · 2020-11-18Molecular docking and binding interaction between psychedelic drugs and human serum albuminBiotechnologia · 2020-06-16"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and cannabinoid research · 2018-01-01Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Clinical pharmacokinetics · 2017-10-01Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.International journal of cardiology · 2009-05-01Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light ConditionsInternational journal of medicinal mushrooms · 2009-01-01